Document is current
Any future updates will be listed below
-
Authors
Fukui, Sho https://orcid.org/0000-0002-3082-1374
Kishimoto, Mitsumasa https://orcid.org/0000-0002-4007-1589
Matsuura, Minoru https://orcid.org/0000-0001-9590-2370
Sakamoto, Aika
Ono, Keisuke https://orcid.org/0000-0002-2651-1509
Kobayashi, Satoshi
Kawashima, Soko
Ikegaya, Noriko
Kawakami, Takahisa
Mitsui, Tatsuya
Saito, Daisuke
Hayashida, Mari https://orcid.org/0000-0002-6267-978X
Miyoshi, Jun https://orcid.org/0000-0002-6883-1930
Komagata, Yoshinori
Hisamatsu, Tadakazu https://orcid.org/0000-0002-1178-3536
-
Funding
Funding for this research was provided by:
School of Medicine, Kyorin University
- License Information
-
More Information
Article History
Received: 30 April 2025
Accepted: 7 September 2025
First Online: 18 September 2025
Declarations
:
: MK received honoraria from AbbVie, Amgen, Asahi-Kasei Pharma, Ayumi Pharma, BMS, Chugai, Daiichi Sankyo, Eisai, Gilead, Janssen, Lilly, Novartis, Pfizer, Tanabe-Mitsubishi, and UCB. MM reports honoraria for lectures from Takeda Pharmaceutical Co. Ltd., AbbVie GK, Janssen Pharmaceutical K.K., Pfizer Inc., Mochida Pharmaceutical Co., Ltd., Kyorin Pharmaceutical Co. Ltd., Mitsubishi Tanabe Pharma Co., Kissei Pharmaceutical Co. Ltd., JIMRO Co., Zeria Pharmaceutical Co. Ltd., and Celltrion Healthcare Japan Co. Ltd. JM reports honoraria from EA Pharma Co., Ltd., AbbVie GK, Janssen Pharmaceutical K.K., Jansen Asia Pacific Pte. Ltd., Pfizer Inc., Mitsubishi Tanabe Pharma Corporation, JIMRO Co., Miyarisan Co., Ltd., and Takeda Pharmaceutical Co., Ltd. T.H. has received grants from AbbVie, Boston Scientific, EA Pharma, JIMRO, Kissei, Kyorin, Mitsubishi Tanabe, Mochida, Nippon Kayaku, Pfizer Inc., Takeda, and Zeria, consulting fees from AbbVie, Bristol Myers Squibb, EA Pharma, Eli Lilly, Gilead Sciences, Janssen, Mitsubishi Tanabe, Nichi-Iko, and Pfizer Inc., and lecture fees from AbbVie, EA Pharma, Janssen, JIMRO, Kissei, Kyorin, Mitsubishi Tanabe, Mochida, Pfizer Inc., and Takeda. The other authors declare no conflicts of interest.
: This study was performed in line with the principles of the Declaration of Helsinki. We obtained a written informed consent from all study participants. Ethical approval was granted by the Ethics Committee of Kyorin University Hospital (approval number: R04-060).
